Risk factors associated with delayed methotrexate clearance and increased toxicity in pediatric patients with osteosarcoma.
Risk factors associated with delayed methotrexate clearance and increased toxicity in pediatric patients with osteosarcoma. Pediatr Blood Cancer. 2020 04; 67(4):e28123.